Department of Epidemiology

喻荣彬

Pubdate:2016-12-26

Yu Rongbin

  

1.  Personal Information

Title/Position:

Professor of Epidemiology, School of Public Health, NJMU

Deputy Director, Educational Administration Office, NJMU

Director, Education Research and Evaluation Center, NJMU

Director, Center for Faculty Development, NJMU

Correspondence Address: Department of Social Medicine and

Health Education, Nanjing Medical University, 101 Longmian Av.,

Jiangning District, Nanjing, Jiangsu Province, 211166, P.R. China.

Telephone: 86-25-86869187

E-mail: rongbinyu@njmu.edu.cn

  

2.  Education

INSTITUTION

DEGREE

(if applicable)

MM/YY

FIELD OF STUDY

Anhui Medical University

B.S.

07/91

Preventive Medicine

Nanjing Medical University

M.Sc.

07/98

Epidemiology and Biostatistics

Nanjing Medical University

Ph.D

07/06

Pathogen Biology

  

3.  Research Interests

Infectious diseases epidemiology (especially such as hepatitis B, C, HIV/AIDS, EIDs )

Behavior epidemiology (measurements, intervention and evaluation in population)

Principles, methods and applications of epidemiology

Data warehouse, processing and statistical analysis in medical research

  

4.  Selected Publications (* Corresponding Author)

1.Peng Huang#, Yuanyuan Zhang#, Xiaomei Lu, Yin Xu, Jie Wang, Yun Zhang, Rongbin Yu*, Jing Su*. Association of Polymorphisms in HLA Antigen Presentation-Related Genes with the Outcomes of HCV Infection. PLoS ONE, 2015, 10(4):e0123513.

2.Peng Huang#, Li Guo Zhu#, Xiang Jun Zhai, Ye Fei Zhu, Ming Yue, Jing Su, Jie Wang, Hai Tao Yang, Yun Zhang, Hong Bing Shen, Zhi Hang Peng*,Rong Bin Yu*. Hepatitis C virus infection and risk factors in the general population: a large community-based study in eastern China, 2011-2012. Epidemiol Infect, 2015,143: 2827-2836.

3.Peng Huang#, Jingguang Tan#, Wenzhe Ma, Hui Zheng, Yan Lu, Ning Wang, Zhihang Peng*, and Rongbin Yu*. Long-Term Effectiveness of Antiretroviral Therapy in China: An Observational Cohort Study from 2003–2014. International journal of environmental research and public health, 2015, 12(8): 8762-8772.

4.Peng Huang, Li Dong, Xiaomei Lu, Yuanyuan Zhang, Hongbo Chen, Jie Wang, Yun Zhang, Jing Su* and Rongbin Yu*. Genetic variants in antigen presentation-related genes influence susceptibility to hepatitis C virus and viral clearance: a case control study. BMC Infectious Diseases, 2014, 14: 716.

5.Yin Xu#, Peng Huang#, Ming Yue, Jing Su, Hongbo Chen, Mingzhu Chen, Jie Wang, Jun Li, Zhihang Peng, Yun Zhang and Rongbin Yu*. A novel polymorphism near HLA class II region is associated with spontaneous clearance of HCV and response to interferon treatment in Chinese patients. Journal of Human Genetics, 2015,61(4): 301-305.

6.Tan Y, Ding K, Su J, Trinh X, Peng Z, Gong Y, Chen L, Cui Q, Lei N, Chen X, Yu R. The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis. PLoS One. 2012, 7(3): e32789.

7.Cui Q, Zhang YX, Su J, Chen X, Ding K, Lei N, Liu Y, Li J, Zhang Y, Yu RB. Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Infect Genet Evol. 2011, 11(7): 1682-9.

8.Shi C, Qian YH, Su J, Luo SS, Gu J, You H, Cui Q, Lin YD, Dong MH, Yu RB. Genetic variation in the LMP/TAP gene and outcomes of hepatitis B virus infection in the Chinese population. Epidemiol Infect. 2011, 139(5):674-82.

9.Qian YH, Su J, Shi P, He EQ,Shao J,Sun N, Zu RQ,Yu RB. Attempted early detection of influenza A (H1N1) pandemic with surveillance data of influenza-like illness and unexplained pneumonia. Influenza Other Resp. 2011, 5(6):e479-86.

10.Cui Q, Su J, Ding K, Lei N, Chen X, Peng Z, Zhang Y, Yu R. The association between genetic polymorphisms of IFNAR2, IL10RB and IL28RA and outcomes of HCV infection in high-risk Chinese population. Hepatol Int. 2011, 5(1): 223

11.Gao X, Cui Q, Su J, Shi X, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R, Wang N. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2011, 11(1):88.

12.Cui Q, Zhang YX, Su J, Shi C, Lei N, Ding K, Li J, Yu RB, Wang L, Wang N.The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users. J Biomed Res.2010, 24(5):1-7

13.Yu RB, Hong X, Ding WL, Tan YF, Zhang YX, Sun NX, Wu GL, Zhan SW, Ge DF. The association between the genetic polymorphism of HLA-DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population. J Gastroenterol Hepatol. 2008, 23(9):1394-1402.

14.Xia X, Luo J, Yu RB. Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008, 122(10): 990-1003.

15.Yu RB, Hong X, Ding WL, Tan YF, Wu GL. Polymorphism of the HLA-DQA1 and -DQB1 genes of Han population in Jiangsu Province, China. Chin Med J. 2006, 119(22):1930-3

  

5.  Scholarly and Professional Activities

Commissioner of the Society of Clinical Epidemiology, China Medical Association (CMA)

Member of the Committee of Comprehensive Prevention and Control for HIV/AIDS, Jiangsu

Commissioner of the Society of Tropical Medicine and parasitology, JMA

Associate Secretary-General of the Society of Sexology, Jiangsu Province